Le Lézard
Classified in: Health, Business
Subject: RTG

HCP Upgraded by S&P Global Ratings to BBB+ with Stable Outlook


IRVINE, Calif., Oct. 31, 2018 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that S&P Global Ratings ("S&P") upgraded its corporate credit rating to BBB+ from BBB, with a stable outlook.

S&P based the ratings upgrade on HCP's repositioning efforts which have improved the quality of the portfolio, reduced tenant concentration and significantly lowered leverage.

"We are pleased that S&P has recognized the significant improvement in our credit profile and our commitment to maintaining a strong balance sheet as we execute our growth initiatives over the coming years," said Pete Scott, HCP's Chief Financial Officer.

The ratings upgrade positively impacts pricing on HCP's $2 billion unsecured credit facility, reducing the spread to 87.5 basis points from 100 basis points over LIBOR and the facility fee to 15 basis points from 20 basis points.

About HCP

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States.  HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing.  Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.  For more information regarding HCP, visit www.hcpi.com.

Contact

Andrew Johns
Vice President ? Finance and Investor Relations
(949) 407-0400

HCP, Inc. Logo. Please visit  www.hcpi.com for more information. (PRNewsFoto/HCP, Inc.) (PRNewsfoto/HCP, Inc.)

 

SOURCE HCP, Inc.


These press releases may also interest you

at 03:05
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....

at 03:00
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...

at 02:11
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...



News published on and distributed by: